Tag Archives: gemcitabine

Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers.  This type of cancer is sensitive to treatment with chemotherapeutic agents.   This type of cancer is usually treated with … Continue reading

Posted in Bladder Cancer, Cancer | Tagged , , , , , , , , , , | Comments Off on Which is Best Chemotherapy Option for Advanced Bladder Cancer?

First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

New Hope for Heavily Pretreated Metastatic Breast Cancer Patients

A new chemotherapy agent, eribulin (developed by Eisai), was shown to improve significant survival benefit in heavily pretreated breast cancer, according to the EMBRACE study presented at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting. The new drug … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , | Comments Off on New Hope for Heavily Pretreated Metastatic Breast Cancer Patients

Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment

Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009.  The high mortality rate is due to the high incidence of metastatic disease … Continue reading

Posted in Pancreatic Cancer | Tagged , , , , , , , , , , , , , , , , | 2 Comments

New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine

Good news for patients with advanced biliary tract cancer.  Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer.  In developed nations, biliary tract cancer … Continue reading

Posted in Cancer, Gallbladder cancer | Tagged , , , , , , | Comments Off on New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine

Alternative Treatment Options for Late Stage Lung Cancer Patients

Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients.  However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading

Posted in Cancer, Lung Cancer | Tagged , , , , , , , , | Comments Off on Alternative Treatment Options for Late Stage Lung Cancer Patients